Results 191 to 200 of about 171,828 (231)
Some of the next articles are maybe not open access.
Biomarkers in Barrett Esophagus
Mayo Clinic Proceedings, 2001Barrett esophagus is a premalignant condition that may progress to adenocarcinoma. The risk of developing cancer has been estimated to be approximately 1 in 250 patient-years of observation; however, there appear to be subsets of patients at much higher risk. Risk stratification has previously been determined by histological identification of dysplasia.
Krishnadath, K. K. +2 more
openaire +2 more sources
BARRETT'S ESOPHAGUS AND ADENOCARCINOMA
Annual Review of Medicine, 1987Barrett's esophagus represents an epithelial metaplasia in which a columnar lining replaces normal squamous epithelium of the esophagus. It occurs in at least 10% of patients with chronic gastroesophageal reflux and is associated with an increased risk of adenocarcinoma of the esophagus.
B J, Reid, W M, Weinstein
openaire +4 more sources
Biomarkers in Barrett's esophagus
Gastrointestinal Endoscopy Clinics of North America, 2003This article provides a framework for clinicians who are attempting the difficult task of interpreting the Barrett's biomarker literature with the goal of improving care for their patients. Although many articles. including more that 60 proposed biomarkers, have been published on this subject, only a few describe phase 3 and 4 studies that are of ...
Brian J, Reid +2 more
openaire +2 more sources
Journal of Gastroenterology and Hepatology
ABSTRACT Barrett's esophagus (BE) is a precancerous condition marked by the replacement of the normal stratified squamous epithelium in the distal esophagus with metaplastic columnar epithelium, typically resulting from chronic gastroesophageal reflux disease (GERD).
Antonio Al Hazzouri +6 more
openaire +2 more sources
ABSTRACT Barrett's esophagus (BE) is a precancerous condition marked by the replacement of the normal stratified squamous epithelium in the distal esophagus with metaplastic columnar epithelium, typically resulting from chronic gastroesophageal reflux disease (GERD).
Antonio Al Hazzouri +6 more
openaire +2 more sources
Gastritis in Barrett's esophagus
World Journal of Surgery, 1995AbstractDuodenogastric reflux has been implicated in the pathogenesis of complicated Barrett's esophagus and gastric ulceration. A group of 123 Barrett's patients were followed for a mean of 41 months; 9 (7%) developed gastric ulceration (GU). Of the Barrett's patients treated by antireflux surgery, 14% developed GU.
R J, Mason, C G, Bremner
openaire +2 more sources
Barrett's Esophagus and Achalasia
Journal of Clinical Gastroenterology, 2002Two unusual cases of achalasia with endoscopic and histologic documentation of Barrett's esophagus are presented. One patient had Barrett's esophagus at the time of initial endoscopy for achalasia, before any treatment. The other patient developed specialized columnar epithelia in the esophagus after treatment with pneumatic dilation.
Jin-Ping, Guo +4 more
openaire +2 more sources
Endomicroscopy of Barrett’s Esophagus
Gastroenterology Clinics of North America, 2010Endomicroscopy is a remarkable technical advance in gastrointestinal mucosa imaging. In 2003, Kiesslich and colleagues described the first human use of contrast-aided confocal laser endomicroscopy (CLE) as a novel technique for in vivo microscopic imaging of the gastrointestinal mucosa.
openaire +2 more sources
The History of Barrett Esophagus
Mayo Clinic Proceedings, 2001The term Barrett esophagus has become well established in the medical literature to indicate columnar metaplasia of the distal esophagus associated with chronic gastroesophageal reflux disease. However, the historical events that led to the use of this term have become obscured.
openaire +2 more sources
Cryotherapy for Barrett’s Esophagus
Gastrointestinal Endoscopy Clinics of North America, 2017Cryotherapy or cryoablation involves the freezing of tissues to destroy unwanted tissue or to control bleeding. Endoscopic cryotherapy has been developed for gastrointestinal application by through-the-scope noncontact delivery of compressed carbon dioxide gas or liquid nitrogen (cryospray) or contact balloon cryoablation.
openaire +2 more sources